Precision BioSciences Inc.

DTIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.11

+$0.61 (+9.38%)

Sep 22, 2026, 2:18 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-45.72M	7.17M	-61.32M	-111.64M	-30.6M	-109.01M
Depreciation & Amortization	2.75M	4.58M	8.26M	9M	10.2M	9.81M
Stock-Based Compensation	10.19M	12.6M	14.04M	19.2M	16.51M	13.79M
Other Working Capital	-24.2M	-62.33M	-42.81M	24.19M	9.21M	8.48M
Other Non-Cash Items	-8.35M	-28.79M	-3.6M	13.57M	-26.55M	35K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-24.71M	-54M	-41.49M	24.11M	19.58M	-2.01M
Operating Cash Flow	-65.84M	-58.45M	-84.11M	-45.75M	-10.85M	-87.39M
Capital Expenditures	-85K	-250K	-2.28M	-3.32M	-5.8M	-5.03M
Cash Acquisitions	n/a	60K	8M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-549K	-25K	107K	n/a	-750K	n/a
Investing Cash Flow	-634K	-215K	5.83M	-3.32M	-5.8M	-5.03M
Debt Repayment	n/a	-37K	n/a	19.81M	2.47M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	249K	401K	835K	7.57M	1.33M
Financial Cash Flow	95.16M	50.45M	5.39M	94.99M	70.52M	1.33M
Net Cash Flow	28.69M	-8.21M	-72.9M	45.91M	53.87M	-91.09M
Free Cash Flow	-65.93M	-58.7M	-86.39M	-49.07M	-16.66M	-92.42M
Adj. Free Cash Flow	-76.11M	-71.3M	-100.43M	-68.27M	-33.17M	-106.2M
Maintenance CapEx	-85K	n/a	n/a	-3.32M	n/a	-1.74M
Growth CapEx	n/a	-250K	-2.28M	n/a	-5.8M	-3.29M
Owner Earnings	-65.93M	-58.45M	-84.11M	-49.07M	-10.85M	-89.13M